Dominant Malignant Clones Leverage Lineage Restricted Epigenomic Programs to Drive Ependymoma Development
Alisha Kardian(Baylor College of Medicine), Stephen C. Mack(Hospital for Sick Children), Shondra M. Pruett‐Miller(Southwestern Medical Center), Kelsey C. Bertrand(University of Toronto), Tuyu Zheng(St. Jude Children's Research Hospital), Jon P. Connelly(St. Jude Children's Research Hospital), Siri Ippagunta(St. Jude Children's Research Hospital), Kimberley Lowe(St. Jude Children's Research Hospital), Srinidhi Varadharajan(Baylor College of Medicine), Benjamin Deneen(Baylor College of Medicine), Erik Emanus(St. Jude Children's Research Hospital), Michael Wang(St. Jude Children's Research Hospital), Nicholas Laboe(St. Jude Children's Research Hospital), Patrick J. Connelly(St. Jude Children's Research Hospital), Hsiao‐Chi Chen(Baylor College of Medicine), Hua Sun(St. Jude Children's Research Hospital), Blake Holcomb(St. Jude Children's Research Hospital)
Cited by 0
Related Papers
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
Rapid “Open-Source” Engineering of Customized Zinc-Finger Nucleases for Highly Efficient Gene Modification
|Molecular Cell|2008|709